Search research articles
Contact Us
Filters
Showing results (101-110 of 138) with videos related to
Page
of 14
Sort By:
Cardiovascular Research
|
December 17, 2008
Differential effects of red and white wines on inhibition of the platelet-derived growth factor receptor: impact of the mash fermentation
Jan Sparwel, Marius Vantler, Evren Caglayan, et al.
Plos One
|
July 14, 2010
Beta1-adrenoceptor polymorphism predicts flecainide action in patients with atrial fibrillation
Amir M Nia, Evren Caglayan, Natig Gassanov, et al.
Plos One
|
March 23, 2012
Clinical impact of atrial fibrillation in patients with pulmonary hypertension
Dennis Rottlaender, Lukas J Motloch, Daniela Schmidt, et al.
Journal of Cardiac Failure
|
October 18, 2008
Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial
Barry F Uretsky, Kristian Thygesen, Jean-Claude Daubert, et al.
European Heart Journal
|
April 14, 2005
Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey
Michel Komajda, Pablo Lapuerta, Nancy Hermans, et al.
Circulation
|
May 11, 2013
Response to letter regarding article, "Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized Pilot RenPro-Trial (Renal Protection Trial)"
Fikret Er, Amir M Nia, Henning Dopp, et al.
American Heart Journal
|
June 22, 2015
Effects of the dual peroxisome proliferator-activated receptor activator aleglitazar in patients with Type 2 Diabetes mellitus or prediabetes
Erland Erdmann, Robert Califf, Hertzel C Gerstein, et al.
European Journal of Heart Failure
|
June 9, 2004
Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS-III
Ronnie Willenheimer, Erland Erdmann, Ferenc Follath, et al.
Diabetes Care
|
August 2, 2007
Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08)
Erland Erdmann, Bernard Charbonnel, Robert G Wilcox, et al.
Circulation
|
June 28, 2012
Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial)
Fikret Er, Amir M Nia, Henning Dopp, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 138) with videos related to
Sort By:
Page
of 14
Cardiovascular Research
|
December 17, 2008
Differential effects of red and white wines on inhibition of the platelet-derived growth factor receptor: impact of the mash fermentation
Jan Sparwel, Marius Vantler, Evren Caglayan, et al.
Plos One
|
July 14, 2010
Beta1-adrenoceptor polymorphism predicts flecainide action in patients with atrial fibrillation
Amir M Nia, Evren Caglayan, Natig Gassanov, et al.
Plos One
|
March 23, 2012
Clinical impact of atrial fibrillation in patients with pulmonary hypertension
Dennis Rottlaender, Lukas J Motloch, Daniela Schmidt, et al.
Journal of Cardiac Failure
|
October 18, 2008
Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial
Barry F Uretsky, Kristian Thygesen, Jean-Claude Daubert, et al.
European Heart Journal
|
April 14, 2005
Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey
Michel Komajda, Pablo Lapuerta, Nancy Hermans, et al.
Circulation
|
May 11, 2013
Response to letter regarding article, "Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized Pilot RenPro-Trial (Renal Protection Trial)"
Fikret Er, Amir M Nia, Henning Dopp, et al.
American Heart Journal
|
June 22, 2015
Effects of the dual peroxisome proliferator-activated receptor activator aleglitazar in patients with Type 2 Diabetes mellitus or prediabetes
Erland Erdmann, Robert Califf, Hertzel C Gerstein, et al.
European Journal of Heart Failure
|
June 9, 2004
Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS-III
Ronnie Willenheimer, Erland Erdmann, Ferenc Follath, et al.
Diabetes Care
|
August 2, 2007
Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08)
Erland Erdmann, Bernard Charbonnel, Robert G Wilcox, et al.
Circulation
|
June 28, 2012
Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial)
Fikret Er, Amir M Nia, Henning Dopp, et al.
Page
of 14